Histone Deacetylase Inhibitors and Mithramycin A Impact a Similar Neuroprotective Pathway at a Crossroad between Cancer and Neurodegeneration

Author： Sleiman Sama F. Berlin Jill Basso Manuela S.Karuppagounder Saravanan Rohr Jürgen Ratan Rajiv R.

Publisher： MDPI

E-ISSN： 1424-8247|4|8|1183-1195

ISSN： 1424-8247

Source： Pharmaceuticals, Vol.4, Iss.8, 2011-08, pp. : 1183-1195

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histone Deacetylase Inhibitors as Anticancer Drugs

By Eckschlager Tomas Plch Johana Stiborova Marie Hrabeta Jan

International Journal of Molecular Sciences, Vol. 18, Iss. 7, 2017-07 ,pp. : 1414-1414

MDPI

Access to resources Recommend Favorite

Clinical Toxicities of Histone Deacetylase Inhibitors

By Subramanian Srividya Bates Susan E. Wright John J. Espinoza-Delgado Igor Piekarz Richard L.

Pharmaceuticals, Vol. 3, Iss. 9, 2010-08 ,pp. : 2751-2767

MDPI

Access to resources Recommend Favorite

Overview of Histone Deacetylase Inhibitors in Haematological Malignancies

By Bishton Mark J. Johnstone Ricky W. Dickinson Michael Harrison Simon Prince H. Miles

Pharmaceuticals, Vol. 3, Iss. 8, 2010-08 ,pp. : 2674-2688

MDPI

Access to resources Recommend Favorite

Novel Proteasome Inhibitors and Histone Deacetylase Inhibitors: Progress in Myeloma Therapeutics

By Chhabra Saurabh

Pharmaceuticals, Vol. 10, Iss. 2, 2017-04 ,pp. : 40-40

MDPI

Access to resources Recommend Favorite

Biological Effect of a Hybrid Anticancer Agent Based on Kinase and Histone Deacetylase Inhibitors on Triple-Negative (MDA-MB231) Breast Cancer Cells

By Librizzi Mariangela Spencer John Luparello Claudio

International Journal of Molecular Sciences, Vol. 17, Iss. 8, 2016-07 ,pp. : 1235-1235

MDPI

Access to resources Recommend Favorite